Workflow
Genmab(GMAB) - 2024 Q4 - Annual Report

Exhibit 99.1 GENMAB 2024 ANNUAL REPORT Table of Contents | MANAGEMENT'S REVIEW | | | --- | --- | | Our 2030 Vision | 1 | | Chair's Statement | 3 | | Letter from the CEO | 4 | | 2024 at a Glance | 5 | | Consolidated Key Figures | 8 | | 2025 Outlook | 10 | | Our Strategy | 12 | | Who We Are | 14 | | Business Model | 15 | | Value Chain | 15 | | Research and Development Capabilities | 18 | | Bringing Our Own Innovative Medicines to Patients | 19 | | Antibody Discovery and Development | 21 | | Products and Techn ...